Researchers report the identification of a new target for the PARP inhibitor drug talazoparib and show that combination treatment with talazoparib and the WEE1 inhibitor adavosertib results in enhanced anti-cancer effects.
source https://www.sciencedaily.com/releases/2021/07/210729143419.htm
Saturday, 31 July 2021
Related Posts
Gut bacteria might be an indicator of colon cancer risk
Coral reefs are 50% less able to provide food, jobs, and climate protection than in 1950s, putting millions at risk
Fossil: New species of otter discovered in Germany
Six stages of engagement in ADHD treatment revealed in new, diverse study
Parental alienation, partner abuse: Two sides of same coin, says social psychologist
Faster research through automation: New way to count micronuclei in cells
0 comments: